Bypass Angioplasty Revascularization Investigation (BARI)

This study has been completed.
Sponsor:
Information provided by:
National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier:
NCT00000462
First received: October 27, 1999
Last updated: June 23, 2005
Last verified: March 2005
  Purpose

To assess the relative long-term safety and efficacy of percutaneous transluminal coronary angioplasty (PTCA) and coronary artery bypass graft (CABG) surgery in patients with multivessel disease and severe angina or ischemia who required revascularization and had coronary anatomy suitable for either procedure.


Condition Intervention Phase
Angina Pectoris
Cardiovascular Diseases
Coronary Disease
Diabetes Mellitus
Heart Diseases
Myocardial Ischemia
Procedure: angioplasty, transluminal, percutaneous coronary
Procedure: coronary artery bypass
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Primary Purpose: Treatment

Resource links provided by NLM:


Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):

Study Start Date: April 1987
Estimated Study Completion Date: November 2004
  Show Detailed Description

  Eligibility

Ages Eligible for Study:   18 Years to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Multivessel coronary artery disease requiring revascularization and suitable for either PTCA or CABG.

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00000462

Sponsors and Collaborators
Investigators
Investigator: Katherine Detre University of Pittsburgh
  More Information

Publications:
BARI Investigators: Protocol for the Bypass Angioplasty Revascularization Investigation. Supplement to Circulation, 84:6, 1991.
Rosen AD: A SAS Interface to System 1032: Writing a user-maintainable interface to data management systems. Proc of Seventeenth Annual SAS Users Group International Conference, Cary, NC, SAS Institute Inc. pp 313, 1992.
Alderman E, Stadius M: The angiographic definitions of the Bypass Angioplasty Revascularization Investigation. Current Science, 3:1189-1207, 1992.
Frye RL, King SB III, Sopko G, et al (Eds): A Symposium: Multivessel PTCA Versus CABG: Baseline Data from the Bypass Angioplasty Revascularization Investigation (BARI) and the Emory Angioplasty Surgery Trial (EAST). Am J Cardiol, 75: 1C-59C, 1995.

ClinicalTrials.gov Identifier: NCT00000462     History of Changes
Other Study ID Numbers: 51
Study First Received: October 27, 1999
Last Updated: June 23, 2005
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Diabetes Mellitus
Cardiovascular Diseases
Heart Diseases
Coronary Disease
Coronary Artery Disease
Myocardial Ischemia
Angina Pectoris
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Vascular Diseases
Arteriosclerosis
Arterial Occlusive Diseases
Chest Pain
Pain
Signs and Symptoms

ClinicalTrials.gov processed this record on September 18, 2014